ArticleMolecules (Basel, Switzerland)2022

Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro.

Ahmed L Alaofi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.